And they just continue to roll out their profit-making poisons and don't give a hoot about what it may do to your child. Why? Because they are exempt from you suing them into bankruptcy . . .

FDA Greenlights Merck’s RSV Shot for Newborns — Clinical Trials Showed 11.71% Rate of Serious Adverse Events, Including Death

The antibody shot will be marketed as Enflonsia and launched this coming RSV season to challenge Sanofi and AstraZeneca’s blockbuster Beyfortus shot. The drug’s clinical trial results posted on ClinicalTrials.gov included serious neurological adverse reactions.​

https://childrenshealthdefense.org/defender/fda-merck-rsv-shot-newborns-clinical-trials-showed-serious-adverse-events-death/
And they just continue to roll out their profit-making poisons and don't give a hoot about what it may do to your child. Why? Because they are exempt from you suing them into bankruptcy . . . FDA Greenlights Merck’s RSV Shot for Newborns — Clinical Trials Showed 11.71% Rate of Serious Adverse Events, Including Death The antibody shot will be marketed as Enflonsia and launched this coming RSV season to challenge Sanofi and AstraZeneca’s blockbuster Beyfortus shot. The drug’s clinical trial results posted on ClinicalTrials.gov included serious neurological adverse reactions.​ https://childrenshealthdefense.org/defender/fda-merck-rsv-shot-newborns-clinical-trials-showed-serious-adverse-events-death/
CHILDRENSHEALTHDEFENSE.ORG
FDA Greenlights Merck’s RSV Shot for Newborns — Clinical Trials Showed 11.71% Rate of Serious Adverse Events, Including Death
The antibody shot will be marketed as Enflonsia and launched this coming RSV season to challenge Sanofi and AstraZeneca’s blockbuster Beyfortus shot. The drug’s clinical trial results posted on ClinicalTrials.gov included serious neurological adverse reactions.
0 Comments 0 Shares 528 Views 0 Reviews
Sponsored
Sponsored
FriendVu https://friendvu.com